Zobrazeno 1 - 10
of 164
pro vyhledávání: '"S, Gerardi"'
Autor:
Demetrius Matassov, Lisa Evans DeWald, Stefan Hamm, Rebecca M. Nowak, Cheryl S. Gerardi, Theresa E. Latham, Rong Xu, Amara Luckay, Tracy Chen, Marc Tremblay, Jeffry Shearer, Melissa Wynn, John H. Eldridge, Kelly Warfield, Kevin Spurgers
Publikováno v:
Vaccines, Vol 12, Iss 8, p 858 (2024)
There are currently no prophylactic vaccines licensed to protect against Lassa fever caused by Lassa virus (LASV) infection. The Emergent BioSolutions (EBS) vaccine candidate, EBS-LASV, is being developed for the prevention of Lassa fever. EBS-LASV i
Externí odkaz:
https://doaj.org/article/5ac6e9310ddd44a58999bee90fd7b27a
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56527230cba36a246302a29c8a270025
https://doi.org/10.2139/ssrn.4307814
https://doi.org/10.2139/ssrn.4307814
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Robert W. Cross, Rong Xu, Susan E. Witko, Ayuko Ota-Setlik, Lena Soukieh, Thomas W. Geisbert, Amara Luckay, Karla A. Fenton, Daniel J. Deer, Krystle N. Agans, John H. Eldridge, Theresa E. Latham, Chad E. Mire, Demetrius Matassov, Heinz Feldmann, Rebecca M. Nowak, Joan B. Geisbert, Christian T. Happi, Cheryl S. Gerardi, Stefan Hamm
Publikováno v:
Journal of Clinical Investigation. 130:539-551
Recent occurrences of filoviruses and the arenavirus Lassa virus (LASV) in overlapping endemic areas of Africa highlight the need for a prophylactic vaccine that would confer protection against all of these viruses that cause lethal hemorrhagic fever
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ff5e32f0f3faea9c6d40d076939d119
https://doi.org/10.1172/jci131958
https://doi.org/10.1172/jci131958
Autor:
V Viglione, Antonio Mazzotti, Cesare Faldini, S Zielli, Giuseppe Geraci, S Gerardi, S Bonelli
Publikováno v:
Foot and ankle surgery : official journal of the European Society of Foot and Ankle Surgeons. 28(5)
Background Currently, there is no consensus on the most appropriate post-operative management for patients undergoing total ankle arthroplasty. The aim of this study is therefore to offer a systematic review of the pertaining literature to identify c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eae4c7de70076bfa9e2a5026ba5d1a63
https://pubmed.ncbi.nlm.nih.gov/34088605
https://pubmed.ncbi.nlm.nih.gov/34088605
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Microbiologia Medica, Vol 21, Iss 3 (2006)
Externí odkaz:
https://doaj.org/article/b4f95c5dcb3949298c50ee469d6246a0
Publikováno v:
Microbiologia Medica, Vol 20, Iss 3 (2005)
Externí odkaz:
https://doaj.org/article/1ac8ca4546f7498cb6a95585d0c3c80c
Autor:
Karla A. Fenton, Ilhem Messaoudi, Robert W. Cross, Daniel J. Deer, Courtney Woolsey, Cheryl S. Gerardi, Joan B. Geisbert, Viktoriya Borisevich, Thomas W. Geisbert, John H. Eldridge, Demetrius Matassov, Krystle N. Agans, Allen Jankeel, Theresa E. Latham, Chad E. Mire
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-18 (2020)
Scientific Reports, Vol 10, Iss 1, Pp 1-18 (2020)
Postexposure immunization can prevent disease and reduce transmission following pathogen exposure. The rapid immunostimulatory properties of recombinant vesicular stomatitis virus (rVSV)-based vaccines make them suitable postexposure treatments again
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f918431681c3f684b30842324b11ca9
https://pubmed.ncbi.nlm.nih.gov/32080323
https://pubmed.ncbi.nlm.nih.gov/32080323
Autor:
David K. Clarke, Theresa E. Latham, Michael A. Egan, Amara Luckay, Lucy A. Ward, Ayuko Ota-Setlik, Terry J. Higgins, Tracy Chen, Rong Xu, Janice M. Rusnak, Marc Tremblay, Susan E. Witko, Demetrius Matassov, Susan Sciotto-Brown, Luz Hermida, Cheryl S. Gerardi, John H. Eldridge
Publikováno v:
The Lancet. Infectious diseases. 20(4)
Summary Background The safety and immunogenicity of a highly attenuated recombinant vesicular stomatitis virus (rVSV) expressing HIV-1 gag (rVSVN4CT1-HIV-1gag1) was shown in previous phase 1 clinical studies. An rVSV vector expressing Ebola virus gly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b81da33fefbeb1d50c33bf76755e0d37
https://pubmed.ncbi.nlm.nih.gov/31952924
https://pubmed.ncbi.nlm.nih.gov/31952924